CBT

Cabot Corporation 10-Q Summary: Quarter Ended June 30, 2005

Business Context and Reporting Period

This filing is a Quarterly Report (Form 10-Q) for Cabot Corporation, a manufacturer of specialty chemicals, tantalum and related products, and cesium formate. The report covers the three and nine-month periods ended June 30, 2005. The Company operates through three reportable segments: Chemicals, Supermetals, and Specialty Fluids.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Net sales increased 11% in the quarter and 9% year-to-date, driven by higher volumes, pricing, and favorable foreign currency translation.
• Profitability Decline: Net income dropped significantly (38% in the quarter; 89% year-to-date). The year-to-date decline is primarily due to a $90 million non-cash goodwill impairment charge recorded in the Supermetals Business segment in the second quarter.
• Margin Compression: Gross margins decreased from 26% to 22% (quarterly) due to rising raw material costs in the Carbon Black business and lower pricing in the Supermetals business as contracts transition from fixed to market-based pricing.
• Restructuring Costs: The Company incurred $4 million in restructuring charges in the quarter and $12 million year-to-date, primarily related to the closure of the Altona, Australia facility and the Zierbena, Spain facility.

Outlook, Risks, and Management Commentary

• Supermetals Impairment: Management determined the fair value of the Supermetals reporting unit was below its carrying amount due to trends toward smaller tantalum capacitors, high supply chain inventory, and expected volume/price decreases. The entire $90 million goodwill balance was written off.
• Carbon Black Feedstock: Rising feedstock costs impacted margins. While pricing formulas exist to recover costs, a time lag in the third quarter resulted in costs exceeding price adjustments. Adjustments effective July 2005 are expected to mitigate this.
• Labor Disputes: A strike at the Boyertown, Pennsylvania Supermetals facility (Local 619C) began June 20, 2005. The plant is operating with supervisory personnel, but incremental costs of $4 million were incurred in the quarter.
• Legal & Regulatory Risks:
  • Respirator Litigation: Approximately 92,500 pending claims related to American Optical Corporation respirators. A reserve of $18 million (undiscounted $32 million) is maintained.
  • Carbon Black Classification: The International Agency for Research on Cancer (IARC) is scheduled to review the carcinogenicity classification of carbon black in February 2006. Reclassification could impact labeling, exposure limits, and customer demand.
  • Antitrust: Civil antitrust lawsuits in the U.S. regarding carbon black price-fixing remain outstanding, though the European Commission closed its investigation in June 2005.
• Financing: On August 3, 2005, the Company replaced its $250 million credit facility with a new $400 million unsecured revolving credit facility expiring in 2010.

Investor Verification Checklist

• Goodwill Impairment: Verify the assumptions used in the discounted cash flow analysis for the Supermetals Business that led to the $90 million write-off.
• Feedstock Cost Recovery: Monitor the effectiveness of pricing formulas in the Carbon Black segment to recover rising raw material costs in subsequent quarters.
• Labor Resolution: Track the duration and cost impact of the strike at the Boyertown facility and the outcome of negotiations with Local 619C.
• Respirator Liability Reserve: Assess the adequacy of the $18 million reserve given the 92,500 pending claims and potential changes in legal interpretations.
• Working Capital: Review the trend in inventory levels (raw materials vs. finished goods) and receivables, which contributed to a decrease in operating cash flow year-to-date.